Intraabdominal infections in the intensive care unit

Journal of Intensive Care Medicine

Volumn 29, Issue 5, 2014, Pages 247-254

  Friedrich, Ann Kristin U ^a   Cahan, Mitchell ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Icu; Intraabdominal infection; Peritonitis; Source control

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ABDOMINAL ABSCESS; ABDOMINAL DRAINAGE; ABDOMINAL INFECTION; ANASTOMOSIS LEAKAGE; ARTICLE; BACTERIAL PERITONITIS; CANDIDA; COMMUNITY ACQUIRED INFECTION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DISEASE CLASSIFICATION; ECHOGRAPHY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE; INTENSIVE CARE UNIT; LAVAGE; MYCOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; CROSS INFECTION; DECISION MAKING; DIAGNOSTIC IMAGING; INTRAABDOMINAL INFECTIONS; MICROBIOLOGY; PROCEDURES;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DECISION MAKING; DIAGNOSTIC IMAGING; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; INTRAABDOMINAL INFECTIONS;

EID: 84928003614     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066613476465     Document Type: Article

References (61)

1. Moss M. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clin Infect Dis. 2005;41(suppl 7):S490-S497.
2. Kalliafas S, Ziegler DW, Flancbaum L, Choban PS. Acute acalculous cholecystitis: Incidence, risk factors, diagnosis and outcome. Am Surg. 1998;64(5):471-476.
3. Leclair MA, Allard C, Lesur O, Pépin J. Clostridium difficile infection in the intensive care unit. J Intensive Care Med. 2010; 25(1):23-30.
4. Anaya DA, Nathens AB. Risk factors for severe sepsis in secondary peritonitis. Surg Infect (Larchmt). 2003;4(4):355-362.
5. de Ruiter J, Weel J, Manusama E, Kingma WP, van der Voort PH. The epidemiology of intra- Abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection. 2009; 37(6):522-527.
6. Blot S, De Waele JJ, Vogelaers D. Essentials for selecting antimicrobial therapy for intra- Abdominal infections. Drugs. 2012; 72(6):e17-e32.
7. Mazuski JE, Solomkin JS. Intra- Abdominal infections. Surg Clin North Am. 2009;89(2):421-437.
8. Sheer TA, Runyon BA. Spontaneous bacterial peritonitis. Dig Dis. 2005;23(1):39-46.
9. Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut. 2012;61(2):297-310.
10. Park JY, Moon SY, Son JS, Lee MS, Jung MH. Unusual primary peritonitis due to Streptococcus pyogenes in a young healthy woman. J Korean Med Sci. 2012;27(5):553-555.
11. Elkassem S, Dixon E, Conly J, Doig C. Primary peritonitis in a young healthy woman: An unusual case. Can J Surg. 2008; 51(2):E40-E41.
12. Saha P, Morewood T, Naftalin J, Hopkins S. Acute abdomen in a healthy woman: primary peritonitis due to group A streptococcus. J Obstet Gynaecol. 2006;26(7):700-701.
13. Moskovitz M, Ehrenberg E, Grieco R, et al. Primary peritonitis due to group A streptococcus. J Clin Gastroenterol. 2000;30(3): 332-335.
14. Hynninen M, Wennervirta J, Leppäniemi A, Pettilä V. Organ dysfunction and long term outcome in secondary peritonitis. Langenbecks Arch Surg. 2008;393(1):81-86.
15. Gauzit R, Péan Y, Barth X, Mistretta F, Lalaude O. Epidemiology, management, and prognosis of secondary non-postoperative peritonitis: A French prospective observational multicenter study. Surg Infect (Larchmt). 2009;10(2):119-127.
16. Riché FC, Dray X, Laisné MJ, et al. Factors associated with septic shock and mortality in generalized peritonitis: comparison between community- Acquired and postoperative peritonitis. Crit Care. 2009;13(3):R99.
17. Berger D, Buttenschoen K. Management of abdominal sepsis. Langenbecks Arch Surg. 1998;383(1):35-43.
18. van Till JW, van Veen SQ, van Ruler O, Lamme B, Gouma DJ, Boermeester MA. The innate immune response to secondary peritonitis. Shock. 2007;28(5):504-517.
19. Malangoni MA. Evaluation and management of tertiary peritonitis. Am Surg. 2000;66(2):157-161.
20. Weiss G, Meyer F, Lippert H. Infectiological diagnostic problems in tertiary peritonitis. Langenbecks Arch Surg. 2006;391(5): 473-482.
21. Buijk SE, Bruining HA. Future directions in the management of tertiary peritonitis. Intensive Care Med. 2002;28(8):1024-1029.
22. Nathens AB, Rotstein OD, Marshall JC. Tertiary peritonitis: clinical features of a complex nosocomial infection. World J Surg. 1998;22(2):158-163.
23. Chromik AM, Meiser A, Hölling J, et al. Identification of patients at risk for development of tertiary peritonitis on a surgical intensive care unit. J Gastrointest Surg. 2009;13(7):1358-1367.
24. Evans HL, Raymond DP, Pelletier SJ, Crabtree TD, Pruett TL, Sawyer RG. Tertiary peritonitis (recurrent diffuse or localized disease) is not an independent predictor of mortality in surgical patients with intraabdominal infection. Surg Infect (Larchmt). 2001;2(4):255-263; discussion 264-265.
25. De Waele JJ, Hoste EAJ, Blot SI. Blood stream infections of abdominal origin in the intensive care unit: characteristics and determinants of death. Surg Infect (Larchmt). 2008:9(2):171-177.
26. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract. The 'undrained abscess' of multiple organ failure. Ann Surg. 1993;218(2):111-119.
27. Montravers P, Gauzit R, Muller C, Marmuse JP, Fichelle A, Desmonts JM. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis. 1996;23(3): 486-494.
28. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillinresistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763-1771.
29. Sitges-Serra A, Lopez MJ, Girvent M, Almirall S, Sancho JJ. Postoperative enterococcal infection after treatment of complicated intra- Abdominal sepsis. Br J Surg. 2002;89(3):361-367.
30. Swenson BR, Metzger R, Hedrick TL, et al. Choosing antibiotics for intra- Abdominal infections: What do we mean by high-risk? Surg Infect (Larchmt). 2009;10(1):29-39.
31. Kaffarnik MF, Urban M, Hopt UT, Utzolino S. Impact of enterococcus on immunocompetent and immunosuppressed patients with perforation of the small or large bowel. Technol Health Care. 2012;20(1):37-48.
32. Harbarth S, Uckay I. Are there patients with peritonitis who require empiric therapy for enterococcus? Eur J Clin Microbiol Infect Dis. 2004;23(2):73-77.
33. Mazuski JE. Vancomycin-resistant entero coccus: risk factors, surveillance, infections, and treatment. Surg Infect (Larchmt). 2008;9(6):567-571.
34. Panhofer P, Izay B, Riedl M, et al. Age, microbiology and prognostic scores help to differentiate between secondary and tertiary peritonitis. Langenbecks Arch Surg. 2009;394(2):265-271.
35. Hughes MG, Chong TW, Smith RL, Evans HL, Pruett TL, Sawyer RG. Comparison of fungal and nonfungal infections in a broadbased surgical patient population. Surg Infect (Larchmt). 2005; 6(1):55-64.
36. Blot SI, Vandewoude KH, De Waele JJ. Candida peritonitis. Curr Opin Crit Care. 2007;13(2):195-199.
37. Montravers P, Dupont H, Gauzit R, et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med. 2006; 34(3):646-652.
38. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management candidiasis: 2009. Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5): 503-535.
39. Sandven P, Qvist H, Skovlund E, Giercksky KE. Significance of Candida recovered from intraoperative specimens in patients with intra- Abdominal perforations. Crit Care Med. 2002;30(3): 541-547.
40. Fierobe L, Decré D, Mùller C, et al. Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intraabdominal infection: relation to nasal colonization. Clin Infect Dis. 1999;29(5):1231-1238.
41. Rau BM, Frigerio I, Büchler MW, et al. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: A prospective, international multicenter study. Arch Surg. 2007;142(2):134-142.
42. Novotny AR, Emmanuel K, Hueser N, et al. Procalcitonin ratio indicates successful surgical treatment of abdominal sepsis. Surgery. 2009;145(1):20-26.
43. Alverdy JC, Saunders J, Chamberlin WH, Moss GS. Diagnostic peritoneal lavage in intra- Abdominal sepsis. Am Surg. 1988; 54(7):456-459.
44. van Ruler O, Kiewiet JJ, van Ketel RJ, Boermeester MA. Initial microbial spectrum in severe secondary peritonitis and relevance for treatment. Eur J Clin Microbiol Infect Dis. 2012;31(5):671-682.
45. Nathens AB. Relevance and utility of peritoneal cultures in patients with peritonitis. Surg Infect (Larchmt). 2001;2(2):153-162.
46. Vincent JL, Sakr Y, Sprung C, Harboe S, Damas P. Are blood transfusions associated with greater mortality rates? Results of the Sepsis Occurrence in Acutely Ill Patients study. Anesthesiology. 2008;108(1):31-39.
47. Rivers EP, Katranji M, Jaehne KA, et al. Early interventions in severe sepsis and septic shock: A review of the evidence one decade later. Minerva Anestesiol. 2012;78(6):712-724.
48. Wong PF, Gilliam AD, Kumar S, Shenfine J, O'Dair GN, Leaper DJ. Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst Rev. 2005;(2): CD004539.
49. Herzog T, Chromik AM, Uhl W. Treatment of complicated intraabdominal infections in the era of multi-drug resistant bacteria. Eur J Med Res. 2010;15(12):525-532.
50. Augustin P, Kermarrec N, Muller-Serieys C, et al. Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Critical Care. 2010;14(1):R20.
51. Eagye KJ, Kuti JL, Nicolau DP. Evaluating empiric treatment options for secondary peritonitis using pharmacodynamic profiling. Surg Infect (Larchmt). 2007;8(2):215-226.
52. Mu YP, Liu RL, Wang LQ, et al. Moxifloxacin monotherapy for treatment of complicated intra- Abdominal infections: A metaanalysis of randomised controlled trials. Int J Clin Pract. 2012; 66(2):210-217.
53. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra- Abdominal infection in adults and children: guidelines by the surgical infection society and the infectious diseases society of America. Clin Infect Dis. 2010; 50(2):133-164.
54. Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev. 2005;(3):CD001439.
55. Schein M, Marshall J. Source control for surgical infections. World J Surg. 2004;28(7):638-645.
56. Schneider CP, Seyboth C, Vilsmaier M, et al. Prognostic factors in critically ill patients suffering from secondary peritonitis: A retrospective, observational, survival time analysis. World J Surg. 2009;33(1):34-43.
57. De Waele JJ. Early source control in sepsis. Langenbecks Arch Surg. 2010;395(5):489-494.
58. Rüttinger D, Kuppinger D, Hölzwimmer M, et al. Acute prognosis of critically ill patients with secondary peritonitis: The impact of the number of surgical revisions, and of the duration of surgical therapy. Am J Surg. 2012;204(1):28-36.
59. Akinci D, Akhan O, Ozmen MN, Karabulut N, Ozkan O. Percutaneous drainage of 300 intraperitoneal abscesses with long-term follow-up. Cardiovasc Intervent Radiol. 2005;28(6):744-750.
60. Evans HL, Raymond DP, Pelletier SJ, Crabtree TD, Pruett TL, Sawyer RG. Diagnosis of intra- Abdominal infection in the critically ill patient. Curr Opin Crit Care. 2001;7(2):117-121.
61. Merlino JI, Malangoni MA, Smith CM, Lange RL. Prospective randomized trials affect the outcomes of intraabdominal infection. Ann Surg. 2001;233(6):859-866.